Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD012464Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 15 diciembre 2016see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Cáncer ginecológico, neurooncología y otros cánceres

Copyright:
  1. Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • George U Eleje

    Correspondencia a: Effective Care Research Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine, College of Health Sciences, Nnamdi Azikiwe University, Nnewi Campus, PMB 5001, Nnewi, Nigeria

    [email protected]

  • Ahizechukwu C Eke

    Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

  • Ifeanyichukwu U Ezebialu

    Department of Obstetrics and Gynaecology, Faculty of Clinical medicine, College of Medicine, Anambra State University Amaku, Awka, Nigeria

  • Joseph I Ikechebelu

    Department of Obstetrics/Gynaecology, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria

  • Emmanuel O Ugwu

    Obstetrics and Gynaecology, University of Nigeria Enugu Campus/University of Nigeria Teaching Hospital Ituko‐Ozalla, Enugu, Nigeria

  • Onyinye O Okonkwo

    Department of Pathology, Tabitha Medical Centre, Abuja, Nigeria

Contributions of authors

George Eleje, Ahizechukwu Eke, Ifeanyichukwu Ezebialu, Joseph Ikechebelu, Emmanuel Ugwu and Onyinye Okonkwo drafted the protocol. All protocol authors read and approved the final protocol draft.

Sources of support

Internal sources

  • None, Other.

External sources

  • National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Gynaecological, Neuro‐oncology and Orphan Cancer Group, UK.

Declarations of interest

George Eleje‐ None known
Ahizechukwu Eke ‐ None known
Ifeanyichukwu Ezebialu ‐ None known
Joseph Ikechebelu ‐ None known
Emmanuel Ugwu ‐ None known
Onyinye Okonkwo ‐ None known

Acknowledgements

We thank Jo Morrison for clinical and editorial advice, Jane Hayes for designing the search strategy and Gail Quinn and Clare Jess for their contribution to the editorial process.

This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Gynaecological, Neuro‐oncology and Orphan Cancer Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2018 Aug 24

Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations

Review

George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo

https://doi.org/10.1002/14651858.CD012464.pub2

2016 Dec 15

Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations

Protocol

George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo

https://doi.org/10.1002/14651858.CD012464

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.